A mobile application could be developed to allow cancer survivors the ability to self-report quality of life experiences to population-based cancer registries. Data would help to learn more about short and long term effects of treatment plans.
Cancer Research Ideas - Implementation Sciences (Archived)
Studying the impact of cancer on large populations can provide important information that influences practices, policies, and programs that directly affect the health of millions of people each year. To improve cancer outcomes, it is essential to identify and test methods for more effectively disseminating information about new approaches for cancer prevention, risk assessment, screening, prognosis, treatment, and survivorship. Interventions must fit within real-world public health and clinical settings and be accessible and understandable to practitioners and the public.
The submission period for Implementation Sciences ideas ended on July 1. However, we encourage you to sign up for regular e-mail updates about the National Cancer Moonshot Initiative at the Cancer Moonshot Milestones web page.
Population-based cancer registries could begin collecting pre-invasive Cervical Intraepithelial Neoplasia (CIN II/III)to help assess the efficacy of current HPV vaccination strategies, and burden of disease across the population.
everything in the body changes throughout the day according to a persons own biorhythms. At the very least you should be tracking whether any of these changes make a difference
Cancer management is a multidisciplinary field, more so with the expansion of the targeted therapeutics. Creation of unbiased, neutral advisory agency available for direct access to the clinicians, patients helps cost-effective quality improvement.
Value for patients should be the main focus of cancer care delivery. Value in cancer care is the outcomes that matter to patients relative to the cost to achieve them. We need to transform our system to one that measures and rewards value.
Clinical research doesn't always translate well into community oncology. We need to better understand differences between academic and community oncology to ensure maximal benefit to all cancer patients
The current system to request and test outside tumor tissue for possible targeted onc meds works poorly and system inefficiencies can limit patient treatment options and delay needed treatment. The system needs to be improved.
Electrochemotherapy is used in the treatment of various forms of superficial cancers (skin) through the use of delivering chemotherapy into the cell interior and using an electrode that sends electrical impulses that permeabilize the cell membrane.
Cancer screenings can lower cancer's economic burden through early detection & treatment. Screenings are lower in specific ethnic groups and income levels. Work-based interventions may increase the prevalence of screenings among these at-risk groups.
Standard antiemetics (e.g. Zofran, Compazine, etc.) do not have a profound affect in preventing nausea and vomiting in most patients undergoing chemotherapy. Emend and Aloxi, together, seem to relieve this hardship for many patients.
Seventeen percent of the overall population smokes, with this number jumping to 25% for those under the poverty line. Cessation treatment is not appropriately covered for many high-prevalence groups.
Risk-reducing medications - like tamoxifen and raloxifene - can cut the risk of breast cancer in high-risk women by around half. Yet, just a small percentage of women who stand to benefit actually take them.
Regular physical activity can lower the risk of multiple cancers and overall mortality. It is also key to weight control - another cancer risk factor. Physical environments that support activity can improve individual health and lower cancer burden.
Rates of HPV vaccination in the US lag behind other countries, and within the US, there are wide regional differences in rates. A doctor recommendation to vaccinate is a key influence on parent's decision to vaccinate children.
Data show that only 65% of US adults overall get recommended colon cancer screenings, with large variability in rates between and within states. Systematic care can help narrow such gaps while improving overall screening rates.